Abstract
Vitamin B6 is involved in a large spectrum of physiological processes and comprises of the vitamers pyridoxamine (PM), pyridoxal (PL), pyridoxine (PN), and their phosphorylated derivatives including the biological active pyridoxal 5'-phosphate (PLP). While PN toxicity is known to complicate several treatments, PM has shown promise in relation to the treatment of metabolic and age-related diseases by blocking oxidative degradation and scavenging toxic dicarbonyl compounds and reactive oxygen species. We aimed to assess the metabolization of oral PM supplements in a single and three daily dose. We optimized and validated a method for the quantification of the B6 vitamers in plasma and urine using ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Five healthy volunteers were recruited to study PM metabolization after a single oral dose of 200mg PM or a three daily dose of 67mg PM. A third protocol was implemented as control for dietary intake. Venous blood samples, 24h urine and fasted second void urine samples were collected. After a single oral dose of 200mg PM, plasma PM increased in the first 3h to a maximum of 2324±266nmol/L. While plasma PM levels returned to baseline after ~10h of PM intake, PLP increased to a maximum of 2787±329nmol/L and reached a plateau. We found a small increase of PN to a maximum of 13.5±2.1nmol/L; it was nearly undetectable after ~12h. With a three daily dose of 67mg PM we observed an increase and decline of plasma PM, PL, and PN concentrations after each PM intake. PLP showed a similar increase as in the single dose protocol and accumulated over time. In this study we showed high plasma levels of PM after oral PM supplementation. We found steadily increasing levels of the biologically active PLP, with minimal formation of PN. The B6 vitamer PM is an interesting supplement as an inhibitor of harmful processes in metabolic diseases and for the treatment of vitamin B6 deficiency. The study was approved by the Medical Ethics Committee of Maastricht University (NL) and was registered at ClinicalTrials.gov as NCT02954588.
Highlights
Background and aimsVitamin B6 is involved in a large spectrum of physiological processes and comprises of the vitamers pyridoxamine (PM), pyridoxal (PL), pyridoxine (PN), and their phosphorylated derivatives including the biological active pyridoxal 50-phosphate (PLP)
Given that most available vitamin B6 supplements contain PN, and PN toxicity is known to complicate several treatments [33e37], we addressed the important question whether the B6 vitamer PM could be a valuable therapeutic supplement for vitamin B6 deficiency by increasing PLP as the biological active form, without PN accumulation
A third protocol was implemented as control for dietary intake and possible vitamin B6 content
Summary
Background and aimsVitamin B6 is involved in a large spectrum of physiological processes and comprises of the vitamers pyridoxamine (PM), pyridoxal (PL), pyridoxine (PN), and their phosphorylated derivatives including the biological active pyridoxal 50-phosphate (PLP). We aimed to assess the metabolization of oral PM supplements in a single and three daily dose. Five healthy volunteers were recruited to study PM metabolization after a single oral dose of 200 mg PM or a three daily dose of 67 mg PM. Results: After a single oral dose of 200 mg PM, plasma PM increased in the first 3 h to a maximum of 2324 ± 266 nmol/L. While plasma PM levels returned to baseline after ~10 h of PM intake, PLP increased to a maximum of 2787 ± 329 nmol/L and reached a plateau. PLP showed a similar increase as in the single dose protocol and accumulated over time. Conclusion: In this study we showed high plasma levels of PM after oral PM supplementation. Clinical trial registry: The study was approved by the Medical Ethics Committee of Maastricht University (NL) and was registered at ClinicalTrials.gov as NCT02954588
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
